Complexity and heterogeneity in demyelinating disease

Brain

Volumn 130, Issue 5, 2007, Pages 1178-1180

  Compston, Alastair ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G;

ANTIBODY TITER; ASTROCYTE; AUTOPSY; BRAIN INFARCTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATING DISEASE; DEMYELINATION; DISEASE MARKER; HISTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NEUTROPHIL COUNT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SENSITIVITY ANALYSIS; SPINAL CORD; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; PATHOLOGY;

AQUAPORIN 4; ASTROCYTES; AUTOANTIBODIES; BIOLOGICAL MARKERS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NERVE; SPINAL CORD;

EID: 34249721428     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm092     Document Type: Note

References (18)

1. Cabre P, Signate A, Olindo S, Merle H, Caparros-Lefebvre D, Bera O, Smadja D. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005; 128: 2899-910.
2. Compston DAS. The marvellous harmony of the nervous parts: the origins of multiple sclerosis. Clin Med 2004; 4: 346-54.
3. Cox A, Coles A, Antoun N, Malik O, Lucchinnetti C, Compston A. Recurrent myelitis and optic neuritis in a 29 year-old woman. Lancet Neurol 2005; 24: 510-6.
4. Devic E. Myélite subaiguë compliquée de névrite optique. Bull Med 1894; 8: 1033.
5. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe Attacks of CNS demyelination: predictors of response. Neurology 2002; 58: 143-6.
6. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005; 366: 579-82.
7. Kira J, Yamasaki K, Horiuchi I, Ohyagi Y, Taniwaki T, Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 1999; 166: 53-7.
8. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-112.
9. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic spinal multiple sclerosis binds to the aquaporin 4 water channel. J Exp Med 2005; 202: 473-77.
10. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple Sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
11. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
12. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-23.
13. Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006; 209: 269-75.
14. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-34.
15. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern Specific Loss of Aquaporin 4 Immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130: 1194-1205.
16. Toshiyuki T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titer. Brain 2007; 130: 1235-43.
17. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
18. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.